Effects of calcitonin gene-related peptide-(8-37) on withdrawal responses in rats with inflammation

European Journal of Pharmacology

Volumn 347, Issue 2-3, 1998, Pages 275-282

  Yu, Long Chuan ^a,c   Hansson, Per ^a,b   Lundeberg, Stefan ^a   Lundeberg, Thomas ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c PEKING UNIVERSITY   (China)

Author keywords

(CGRP 8 37) (calcitonin gene related peptide 8 37); Carrageenan; Hindpaw withdrawal latency; Inflammation; Intrathecal injection; Morphine

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE[8-37]; CARRAGEENAN; MORPHINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; INFLAMMATION; INTRATHECAL DRUG ADMINISTRATION; LATENT PERIOD; MALE; MECHANICAL STIMULATION; NOCICEPTIVE STIMULATION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THERMAL STIMULATION; WITHDRAWAL REFLEX;

ANALGESICS, OPIOID; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CARRAGEENAN; COLD; HEAT; HINDLIMB; INFLAMMATION; INJECTIONS, SPINAL; MALE; MORPHINE; PAIN; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032562440     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00102-2     Document Type: Article

References (35)

1. Attal N., Jazat F., Kayser V., Guilbaud G. Further evidence for 'pain-related' behaviours in a unilateral peripheral mononeuropathy. Pain. 41:1990;235-251.
2. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
3. Biella G., Panara C., Pecile A., Satgiu M.L. Facilatatory role of calcitonin gene-related peptide (CGRP) on excitation induced by substance P and noxious stimuli in rat spinal dorsal horn neurones: An iontophoretic study in vivo. Brain Res. 559:1991;352-356.
4. Bileviciute I., Lundeberg T., Ekblom A., Theodorsson E. Bilateral changes of substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity in rat knee joint synovial fluid during acute monoarthritis. Neurosci. Lett. 153:1993;37-40.
5. Bileviciute I., Lundeberg T., Ekblom A., Theodorsson E. Substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity (-LI) in rat knee joint synovial fluid during acute monoarthritis is not correlated with concentrations of neuropeptides-LI in cerebrospinal fluid and plasma. Neurosci. Lett. 167:1994;145-148.
6. Brain S.D., Williams T.J. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br. J. Pharmacol. 86:1985;855-860.
7. Brain S.D., Williams T.J. Interaction between the tachykinins and calcitonin gene-related peptide lead to the modulation of oedema formation and blood flow in rat skin. Br. J. Pharmacol. 97:1989;77-82.
8. Carlton S.M., Lekan H.A., Kim S.H., Chung J.M. Behavioral manifestations of an experimental peripheral neuropathy produced by spinal nerve ligation in the primate. Pain. 56:1994;155-166.
9. Chiba T., Yamaguchi A., Yamatani T., Nakamura A., Morishita T., Inui T., Fukas M., Noda T., Fujita T. Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am. J. Physiol. 256:1989;E331-E335.
10. Collin E., Frechilla D., Pohl M., Bourgoin S., Bars D.L., Hamon M., Cesselin F. Opioid control the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo. Brain Res. 609:1993;211-222.
11. Dickenson A.H. Spinal cord pharmacology of pain. Br. J. Anaesth. 75:1995;193-201.
12. Dray A. Inflammatory mediators of pain. Br. J. Anaesth. 75:1995;125-137.
13. Dray A., Bevan S. Inflammation and hyperalgesia: highlighting the team effort. Trends Pharmacol. Sci. 14:1993;287-290.
14. Duggan A.W., Hendry I.A., Morton C.R., Hutchison W.D., Zhao Z.Q. Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat. Brain Res. 451:1988;261-273.
15. Kawamura M., Kuraishi Y., Minami M., Satoh M. Antinociceptive effect of intrathecally administered antiserum against calcitonin gene-related peptide on thermal and mechanical noxious stimuli in experimental hyperalgesic rats. Brain Res. 497:1989;199-203.
16. Lundeberg T., Meister B., Björkstrand E., Uvnäs-Moberg K. Oxytocin modulates the effects of galanin in carrageenan-induced hyperalgesia in rats. Brain Res. 608:1993;181-185.
17. Maggi C.A. Tachykinins and calcitonin gene-related peptide (CGRP)as co-transmitters released from peripheral endings of sensory nerves. Prog. Neurobiol. 45:1995;1-98.
18. Malcangio M., Bowery N.G. Calcitonin gene-related peptide content, basal outflow and electrically-evoked release from monoarthritic rat spinal cord in vitro. Pain. 66:1996;351-358.
19. Mayer E.A., Raybould H., Koelbel C. Neuropeptides, inflammation, and motility. Digest. Dis. Sci. 33:1988;71S-77S.
20. Menard D.P., van Rossum D., Kar S., St. Pierre S., Sutak M., Jhamandas K., Quirion R. A calcitonin gene-related peptide receptor antagonist prevents the development of tolerance to spinal morphine analgesia. J. Neurosci. 17:1996;2342-2351.
21. Millan M.J., Czlonkowski A., Morris B., Stein C., Arendt R., Huber A., Höllt V., Herz A. Inflammation of the hind limb as a model of unilateral, Localized pain: influence on multiple opioid system in the spinal cord of the rat. Pain. 35:1988;299-312.
22. Neugebauer V., Rumenapp P., Schaible H.-G. Calcitonin gene-related peptide is involved in the spinal processing of mechanosensory input from the rats knee joint and in the generation and maintenance of hyperexcitability of dorsal horn neurons during development of acute inflammation. Neuroscience. 71:1996;1095-1109.
23. Pohl M., Lombard M.C., Bourgoin S.S., Benoliel J.J., Mauborgne A., Besson J.M., Hamon M., Cesselin F. Opioid control of the in vitro release gene-related peptide from primary afferent fibers projecting in the rat cervical cord. Neuropeptides. 14:1989;151-159.
24. Raud J., Lundeberg T., Brodda-Jansen G., Theodorsson E., Hedqvist P. Potent anti-inflammatory action of calcitonin gene-related peptide. Biochem. Biophys. Res. Comm. 180:1991;1429-1435.
25. Satoh M., Kuraishi Y., Kawamura M. Effects of intrathecal antibodies to substance P, calcitonin gene-related peptide and galanin on repeated cold stress-induced hyperalgesia: comparison with carrageenan-induced hyperalgesia. Pain. 49:1992;273-278.
26. Sluka K.A., Willis W.D., Westlund K.N. The role of dorsal root reflexes in neurogenic inflammation. Pain Forum. 4:1995;141-149.
27. Traub R.J. The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat. Pain. 67:1996;151-161.
28. Vinegar R., Schreiber W., Hugo R. Biphasic development of carrageenin edema in rats. J. Pharmacol. Exp. Ther. 166:1969;96-103.
29. Winter C.A., Risley E.A., Nuss G.W. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exp. Biol. Med. 111:1962;544-547.
30. Xu X.J., Wiesenfeld-Hallin Z. Calcitonin gene-related peptide (8-37) does not antagonize calcitonin gene-related peptide in rat spinal cord. Neurosci. Lett. 204:1996;185-188.
31. Yaksh T.L., Michener S.R., Bailey J.E., Harty G.L., Lucas D.L., Nelson D.K., Roddy D.R., Go V.L. Survey of distribution of substance P, vasoactive intestinal polypeptide, cholecystokinin, neurotensin, Met-enkephalin, bombesin and PHI in the spinal cord of the cat, dog, sloth and monkey. Peptides. 9:1988;357.
32. 8-37 increases the latency to withdrawal responses in rats. Brain Res. 653:1994;223-230.
33. 8-37 in rats. Brain Res. 698:1995;23-29.
34. 8-37 results in a bilateral increase in hindpaw withdrawal latency in rats with experimentally induced unilateral inflammation. Br. J. Pharmacol. 117:1996;43-50.
35. 8-37 increases the latency to withdrawal responses bilaterally in rats with experimental mononeuropathy, an effect reversed by naloxone. Neuroscience. 71:1996;523-531.